CNW/ - Highlights A$14.1M Entitlement Offer Fully Subscribed Completion of Entitlement Offer to all eligible shareholders, ...
This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback